Updated prostate tissue ablation device receives 510(k) clearance
SonaCare Medical has received 510(k) regulatory clearance to market the latest version of its prostate tissue ablation device, Sonablate. The improved version includes updates and new features including Tissue Change Monitoring (TCM), which quantifies radiofrequency signals for changes in tissue composition following energy delivery. It also features an altered delivery sequence that reduces overall procedure time by as much as 40%, according to SonaCare. The look and software interface have also been updated.
For more information, visit www.sonacaremedical.com.